Beta Bionics, Inc./$BBNX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Beta Bionics, Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Ticker
$BBNX
Sector
Primary listing
Employees
422
Headquarters
Website
BBNX Metrics
BasicAdvanced
$641m
-
-$1.51
-
-
Price and volume
Market cap
$641m
52-week high
$32.71
52-week low
$8.80
Average daily volume
822k
Financial strength
Current ratio
10.693
Quick ratio
9.385
Long term debt to equity
1.87
Total debt to equity
2.548
Profitability
EBITDA (TTM)
-75.455
Gross margin (TTM)
57.15%
Net profit margin (TTM)
-60.27%
Operating margin (TTM)
-70.13%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
-15.04%
Return on equity (TTM)
-22.71%
Valuation
Price to revenue (TTM)
5.734
Price to book
2.36
Price to tangible book (TTM)
2.36
Price to free cash flow (TTM)
-10.342
Free cash flow yield (TTM)
-9.67%
Free cash flow per share (TTM)
-1.39
Growth
Revenue change (TTM)
57.87%
Earnings per share change (TTM)
-73.30%
BBNX News
AllArticlesVideos
Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX)
Business Wire·1 day ago
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth
Newsfile Corp·1 week ago
Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel
Business Wire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs